The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Activity and duration of chemotherapy (CT) in different biologic subtype (BS) in metastatic breast cancer (MBC) patients (P).
Claudia Bighin
No relevant relationships to disclose
Lucia Del Mastro
No relevant relationships to disclose
Beatrice Dozin
No relevant relationships to disclose
Sara Giraudi
No relevant relationships to disclose
Alessia Levaggi
No relevant relationships to disclose
Alessia D'Alonzo
No relevant relationships to disclose
Matteo Lambertini
No relevant relationships to disclose
Francesca Poggio
No relevant relationships to disclose
Giuseppina Iacono
No relevant relationships to disclose
Loredana Miglietta
No relevant relationships to disclose
Paolo Pronzato
No relevant relationships to disclose